SQUAD

The mark consists of the stylized word "SQUAD" that appears in blue. Above the word "SQUAD" are three hexagons arranged horizontally. In the center is a gray hexagon with a gray circle above it, overlapping with left side of the gray hexagon is a smaller purple hexagon with a purple circle above it, and overlapping with the right side of the gray hexagon is a smaller blue hexagon with a blue circle above it. The white in the mark represents merely background and is not claimed as part of the mark.

Mark For: SQUAD™ trademark registration is intended to cover the categories of conducting clinical trials for coronavirus and COVID-19 vaccines; providing information about the results of clinical trials for coronavirus and COVID-19 vaccines; providing medical and scientific research information in the field of coronavirus and COVID-19 vaccines and coronavirus and COVID-19 vaccine clinical trials. [all]

>The color(s) purple, gray and blue is/are claimed as a feature of the mark. The mark consists of the stylized word "SQUAD" that appears in blue. Above the word "SQUAD" are three hexagons arranged horizontally. In the center is a gray hexagon with a gray circle above it, overlapping with left side of the gray hexagon is a smaller purple hexagon with a purple circle above it, and overlapping with the right side of the gray hexagon is a smaller blue hexagon with a blue circle above it. The white in the mark represents merely background and is not claimed as part of the mark.

Status

2020-11-15 UTC
⟳ Refresh

LIVE APPLICATION Awaiting Examination

Research	OneLook Acronym Finder
Serial Number	90302869
Mark Literal Elements	SQUAD
Mark Drawing Type	-
Mark Type	SERVICE MARK
Standard Character Claim	No
Register	PRINCIPAL
Current Location	NEW APPLICATION PROCESSING 2020-11-10
Basis	1(b)
Class Status	ACTIVE
Primary US Classes	100: Miscellaneous 101: Advertising and Business
Primary International Class	042 - Primary Class (Computer, scientific & legal) Scientific and technological services and research and design relating thereto: industrial analysis and research services; design and development of computer hardware and software; legal services.
Filed Use	No
Current Use	No
Intent To Use	Yes
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Domestic Representative	Fross Zelnick Lehrman & Zissu, P.C.
Attorney Name	Nancy Sabarra
Attorney Docket Number	SEQI 2011145

Timeline

IC 042. US 100 101. G & S: Conducting clinical trials for coronavirus and COVID-19 vaccines; providing information about the results of clinical trials for coronavirus and COVID-19 vaccines; providing medical and scientific research information in the field of coronavirus and COVID-19 vaccines and coronavirus and COVID-19 vaccine clinical trials